Results 21 to 30 of about 1,486,593 (315)

Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges. [PDF]

open access: yes, 2012
New proposed criteria for the clinical diagnosis of Alzheimer's disease increasingly incorporate biomarkers, most of which are normally measured on a continuous scale. Operationalizing such criteria thus requires continuous biomarkers to be dichotomized,
Skillbäck, Tobias,   +10 more
core   +1 more source

Phospholipids profiling and outcome of peritoneal dialysis patients [PDF]

open access: yes, 2014
Objectives: To investigate phospholipids (PLs) biomarkers in predicting outcome of patients undergoing peritoneal dialysis (PD). Materials and methods: Twenty PD patients were followed using baseline plasma PLs with an improved online two-dimensional ...
Li, Min   +4 more
core   +1 more source

Proteomic candidate biomarkers of drug-induced nephrotoxicity in the rat [PDF]

open access: yes, 2012
Improved biomarkers of acute nephrotoxicity are coveted by the drug development industry, regulatory agencies, and clinicians. In an effort to identify such biomarkers, urinary peptide profiles of rats treated with two different nephrotoxins were ...
Hanig, J.   +23 more
core   +1 more source

Integration of Proteomics, Bioinformatics and Systems biology in Brain Injury Biomarker Discovery

open access: yesFrontiers in Neurology, 2013
Traumatic brain injury (TBI) is a major medical crisis without any FDA-approved pharmacological therapies that have been demonstrated to improve functional outcomes.
Joy eGuingab-Cagmat   +3 more
doaj   +1 more source

Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumors

open access: yesBiomarker Research, 2023
Background Activated immune cells (IC) in the tumor microenvironment (TME) are critical for anti-tumor efficacy. Greater understanding of the dynamic diversity and crosstalk between IC is needed to clarify their association with immune checkpoint ...
Dingwei Ye   +16 more
doaj   +1 more source

Traditional and Digital Biomarkers: Two Worlds Apart? [PDF]

open access: yes, 2019
The identification and application of biomarkers in the clinical and medical fields has an enor - mous impact on society. The increase of digital devices and the rise in popularity of health- related mobile apps has produced a new trove of biomarkers ...
Miho, Enkelejda, Babrak, Lmar
core   +1 more source

The Current Landscape of Glioblastoma Biomarkers in Body Fluids [PDF]

open access: yes, 2023
Glioblastoma (GBM) is a highly aggressive and lethal primary brain cancer that necessitates early detection and accurate diagnosis for effective treatment and improved patient outcomes.
Mohammad Doroudian   +5 more
core   +1 more source

The potential of pathological protein fragmentation in blood-based biomarker development for dementia – with emphasis on Alzheimer’s disease

open access: yesFrontiers in Neurology, 2015
The diagnosis of dementia is challenging and early stages are rarely detected limiting the possibilities for early interven-tion. Another challenge is the overlap in the clinical features across the different dementia types leading to difficulties in the
Dilek eInekci   +4 more
doaj   +1 more source

Functional polymorphisms of caveolin-1 variants as potential biomarkers of esophageal squamous cell carcinoma [PDF]

open access: yes, 2014
Objective: To investigate the association of caveolin-1 (CAV1) genetic variants (C239A (rs1997623), G14713A (rs3807987), G21985A (rs12672038), T29107A (rs7804372)) with esophageal squamous cell carcinoma (ESCC) susceptibility.
Chen, Ziping   +9 more
core   +1 more source

The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey [PDF]

open access: yes, 2014
We investigated the use of Alzheimer's disease (AD) biomarkers in European Alzheimer's Disease Consortium centers and assessed their perceived usefulness for the etiologic diagnosis of mild cognitive impairment (MCI).
Erikdotter, M   +197 more
core   +1 more source

Home - About - Disclaimer - Privacy